Explore more publications!

The Middle East Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Gazette.

Press releases published on March 25, 2026

Radha Krishna Machine Tools Expands Industrial Offerings with Bulk Loose Gears & Sprockets Supply Across India
Ignite Completes First Phase of Local Assembly Lines Built Up Across Four African Markets
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Integral Metals Appoints Leo Power to Board of Directors
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
Crypto News: Pepeto Announces Presale Stage Sold Out While XRP Price Price Prediction Signals Breakout Toward $8
Outlook Therapeutics Announces Closing of $5.0 Million Public Offering
Crypto News: Pepeto Binance Listing Update While Bitcoin Price Prediction Targets $100K Following Trump Geopolitical Context
Crypto News: Ethereum Based Crypto Pepeto Approaches Binance Listing While Cardano Price Prediction Eyes Strong Recovery
Chuanchuanli at Canton Fair: A High Quality PVC Butterfly Valve factory from China Update
Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration
Cyabra and Orchestra Partner to Deliver Real-Time Brand Safety at Scale
DB Investing Launches DB Pay — Where Fiat Meets Digital on a Single Powerful Platform
Tower Semiconductor Announces Plans to Expand 300mm Capacity in Japan to Support Strong Customer Demand
VIVUS bekræfter den kliniske effektivitet og sikkerhed af QSIVA® i behandlingen af fedme
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
VIVUS vahvistaa QSIVAn® kliinistä tehoa ja turvallisuutta lihavuuden hallinnassa
VIVUS förstärker budskapet om klinisk effekt och säkerhet för QSIVA® vid behandling av obesitas
Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions